Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Suzuki

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Burns : Journal of the International Society for Burn Injuries|October 2, 2010
Introduction of human β-defensin-3 into cultured human keratinocytes and fibroblasts by infection of a recombinant adenovirus vectorYosuke Suzuki, Sadaki Inokuchi, Kensuke Takazawa, et al.
Pharmacological Reports : PR|March 4, 2019
Factors involved in phenoconversion of CYP3A using 4β-hydroxycholesterol in stable kidney transplant recipientsYosuke Suzuki, Nanako Muraya, Takashi Fujioka, et al.
British Journal of Clinical Pharmacology|January 17, 2016
CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal diseaseYosuke Suzuki, Takashi Fujioka, Fuminori Sato, et al.
Journal of Separation Science|March 5, 2022
Highly sensitive simultaneous quantification of indoxyl sulfate and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high-performance liquid chromatography coupled with tandem mass spectrometryAyako Oda, Yosuke Suzuki, Banri Sato, et al.
British Journal of Clinical Pharmacology|December 15, 2022
Positive correlation between organic anion transporter 1B function indicated by plasma concentration of coproporphyrin-I and blood concentration of cyclosporin A in real-world patientsTakuma Watanabe, Ryota Tanaka, Yosuke Suzuki, et al.
Clinical Pharmacology and Therapeutics|July 28, 2021
Factors Influencing Plasma Coproporphyrin-I Concentration as Biomarker of OATP1B Activity in Patients With Rheumatoid ArthritisHiroyuki Ono, Ryota Tanaka, Yosuke Suzuki, et al.
Scientific Reports|November 10, 2021
Association between MR-proADM concentration and treatment intensity of antihypertensive agents in chronic kidney disease patients with insufficient blood pressure controlMotoshi Iwao, Ryota Tanaka, Yosuke Suzuki, et al.
British Journal of Clinical Pharmacology|July 31, 2023
Evaluation of effects of indoxyl sulfate and parathyroid hormone on CYP3A activity considering the influence of CYP3A5 gene polymorphismsAyako Oda, Yosuke Suzuki, Chisato Yoshijima, et al.
Frontiers in Immunology|March 14, 2022
Amelioration of Endotoxemia by a Synthetic Analog of Omega-3 EpoxyeicosanoidsAkira Shikuma, Daisuke Kami, Ryotaro Maeda, et al.
Clinical Case Reports|March 26, 2021
Significant elevation of free itraconazole concentration at onset of adverse effects: A case reportRyota Tanaka, Yosuke Suzuki, Hiroyuki Matsumoto, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Burns : Journal of the International Society for Burn Injuries|October 2, 2010
Introduction of human β-defensin-3 into cultured human keratinocytes and fibroblasts by infection of a recombinant adenovirus vectorYosuke Suzuki, Sadaki Inokuchi, Kensuke Takazawa, et al.
Pharmacological Reports : PR|March 4, 2019
Factors involved in phenoconversion of CYP3A using 4β-hydroxycholesterol in stable kidney transplant recipientsYosuke Suzuki, Nanako Muraya, Takashi Fujioka, et al.
British Journal of Clinical Pharmacology|January 17, 2016
CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal diseaseYosuke Suzuki, Takashi Fujioka, Fuminori Sato, et al.
Journal of Separation Science|March 5, 2022
Highly sensitive simultaneous quantification of indoxyl sulfate and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high-performance liquid chromatography coupled with tandem mass spectrometryAyako Oda, Yosuke Suzuki, Banri Sato, et al.
British Journal of Clinical Pharmacology|December 15, 2022
Positive correlation between organic anion transporter 1B function indicated by plasma concentration of coproporphyrin-I and blood concentration of cyclosporin A in real-world patientsTakuma Watanabe, Ryota Tanaka, Yosuke Suzuki, et al.
Clinical Pharmacology and Therapeutics|July 28, 2021
Factors Influencing Plasma Coproporphyrin-I Concentration as Biomarker of OATP1B Activity in Patients With Rheumatoid ArthritisHiroyuki Ono, Ryota Tanaka, Yosuke Suzuki, et al.
Scientific Reports|November 10, 2021
Association between MR-proADM concentration and treatment intensity of antihypertensive agents in chronic kidney disease patients with insufficient blood pressure controlMotoshi Iwao, Ryota Tanaka, Yosuke Suzuki, et al.
British Journal of Clinical Pharmacology|July 31, 2023
Evaluation of effects of indoxyl sulfate and parathyroid hormone on CYP3A activity considering the influence of CYP3A5 gene polymorphismsAyako Oda, Yosuke Suzuki, Chisato Yoshijima, et al.
Frontiers in Immunology|March 14, 2022
Amelioration of Endotoxemia by a Synthetic Analog of Omega-3 EpoxyeicosanoidsAkira Shikuma, Daisuke Kami, Ryotaro Maeda, et al.
Clinical Case Reports|March 26, 2021
Significant elevation of free itraconazole concentration at onset of adverse effects: A case reportRyota Tanaka, Yosuke Suzuki, Hiroyuki Matsumoto, et al.
Pageof 15